These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12131362)

  • 1. Prostate specific antigen inhibits immune responses in vitro: a potential role in prostate cancer.
    Kennedy-Smith AG; McKenzie JL; Owen MC; Davidson PJ; Vuckovic S; Hart DN
    J Urol; 2002 Aug; 168(2):741-7. PubMed ID: 12131362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen.
    Aalamian M; Tourkova IL; Chatta GS; Lilja H; Huland E; Huland H; Shurin GV; Shurin MR
    J Urol; 2003 Nov; 170(5):2026-30. PubMed ID: 14532846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
    Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.
    Chakraborty NG; Stevens RL; Mehrotra S; Laska E; Taxel P; Sporn JR; Schauer P; Albertsen PC
    Cancer Immunol Immunother; 2003 Aug; 52(8):497-505. PubMed ID: 12783216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.
    Lubaroff DM; Karan D
    Adv Drug Deliv Rev; 2009 Mar; 61(3):268-74. PubMed ID: 19166887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence and specificity of tumor associated lymphocytes from ascites fluid in prostate cancer.
    Ozenci V; Miller AM; Palmborg A; Egevad L; Jaremko GA; Kälkner KM; Pisa P
    Prostate; 2005 Sep; 65(1):20-6. PubMed ID: 15800933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantation.
    Uhlin M; Okas M; Karlsson H; Gertow J; Henningsohn L; Ringdén O; Kärre K; Levitsky V; Mattsson J
    Transplantation; 2009 Feb; 87(4):467-72. PubMed ID: 19307781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patients.
    Harada M; Kobayashi K; Matsueda S; Nakagawa M; Noguchi M; Itoh K
    Prostate; 2003 Oct; 57(2):152-9. PubMed ID: 12949939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary evidence that the allogeneic response might trigger antitumour immunity in patients with advanced prostate cancer.
    Muir G; Rajbabu K; Callen C; Fabre JW
    BJU Int; 2006 Nov; 98(5):989-95. PubMed ID: 16879440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer.
    Elkord E; Williams PE; Kynaston H; Rowbottom AW
    Int Immunol; 2005 Oct; 17(10):1315-25. PubMed ID: 16141246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
    Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine.
    Marshall DJ; San Mateo LR; Rudnick KA; McCarthy SG; Harris MC; McCauley C; Schantz A; Geng D; Cawood P; Snyder LA
    Cancer Immunol Immunother; 2005 Nov; 54(11):1082-94. PubMed ID: 16047142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
    Roos AK; Pavlenko M; Charo J; Egevad L; Pisa P
    Prostate; 2005 Feb; 62(3):217-23. PubMed ID: 15389792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology and immunotherapy approaches for prostate cancer.
    Elkord E
    Prostate Cancer Prostatic Dis; 2007; 10(3):224-36. PubMed ID: 17420764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo.
    Denmeade SR; Litvinov I; Sokoll LJ; Lilja H; Isaacs JT
    Prostate; 2003 Jun; 56(1):45-53. PubMed ID: 12746846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.
    Debes JD; Comuzzi B; Schmidt LJ; Dehm SM; Culig Z; Tindall DJ
    Cancer Res; 2005 Jul; 65(13):5965-73. PubMed ID: 15994976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion.
    Ishii K; Otsuka T; Iguchi K; Usui S; Yamamoto H; Sugimura Y; Yoshikawa K; Hayward SW; Hirano K
    Cancer Lett; 2004 Apr; 207(1):79-87. PubMed ID: 15050736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA-DRB1*1501-restricted T-cell epitopes from prostate-specific antigen.
    Klyushnenkova EN; Link J; Oberle WT; Kodak J; Rich C; Vandenbark AA; Alexander RB
    Clin Cancer Res; 2005 Apr; 11(8):2853-61. PubMed ID: 15837732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcitriol on prostate-specific antigen in vitro and in humans.
    Beer TM; Garzotto M; Park B; Mori M; Myrthue A; Janeba N; Sauer D; Eilers K
    Clin Cancer Res; 2006 May; 12(9):2812-6. PubMed ID: 16675575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.